Insights Science, market, regulatory

Science decoded, the business angle included.

Ingredient markets, clinical studies under scrutiny, regulatory, AI visibility. Every insight is sourced — PubMed, EFSA, dated reports — and ends with what it changes for your pipeline.

Insights — Page 3

Ingredients

Plant-based or animal proteins: the source leaves a microbial footprint

Plant-based or animal-based proteins: a machine learning study shows that the source leaves a distinct microbial fingerprint, predicted with 88% accuracy.

Read the insight
Science

If Europeans shun insects, it might be genetic

Why do Europeans reject edible insects? A 2026 study shows that this aversion has been encoded in their genome for 9,000 years.

Read the insight
Food transition

At the same calorie count, ultra-processed foods still make you gain weight

Ultra-processed food leads to weight gain even when calorie intake is equal. What a controlled trial reveals and why processing has become a health variable.

Read the insight
Health & clinical

Reducing the risk of diabetes: should you avoid chips?

Chips and type 2 diabetes: Harvard-BMJ (205,000 people) shows a 20% higher risk. The issue is the frying process, not the potato itself.

Read the insight
Ingredients

Patrice Cani, the scientist illuminating the future of health through the microbiome

Patrice Cani, winner of the 2026 Francqui-Collen Prize, is transforming our understanding of the microbiota. Discover his work on Akkermansia and metabolic health.

Read the insight
Consumer brands

How taste overtakes clean label in 2026

Clean label = a prerequisite, not a selling point. 52% of US shoppers prioritise taste. How can we bridge the sensory gap without compromising on naturalness?

Read the insight
Food transition

FDA front-of-pack: why the delay in the rule complicates manufacturers' strategy

The FDA did not publish its front-of-pack rule in 2026. This delay fragments regulation, strengthens MAHA pressure and weighs on manufacturers' strategies.

Read the insight
Consumer brands

Intermittent Fasting and Cochrane: The Marketing of Fasting Has a Problem (and It's an Opportunity)

A Cochrane review concludes that intermittent fasting is no better than conventional diets for weight loss. Implications for nutrition marketing.

Read the insight
Ingredients

Oral collagen: what science really says (and what marketing forgets to mention)

Oral collagen: a meta-analysis of 113 trials confirms benefits for skin and osteoarthritis, but no effect on sports performance.

Read the insight
Science

Beige fat: when the intestinal microbiota does the work that diet alone cannot do

Microbiota and beige fat: a Nature study shows how intestinal bacteria activate thermogenesis via FGF21 and bile acids.

Read the insight
Science

Snacking: your brain says yes long before you're hungry

Snacking: a neuroscience study shows that the brain continues to value snacks even after satiety. Our analysis.

Read the insight
Ingredients

National food, nutrition and climate strategy (SNANC) 2025-2030: what impact on ingredients?

The SNANC 2025-2030 redefines nutrition and climate. What concrete impact will this have on reformulation and food ingredients?

Read the insight